Is AOD-9604 legal in South Dakota?
status · caveats apply
No FDA approval; WADA explicitly names AOD-9604 as a prohibited example under S2.2; PCAC discussed December 4, 2024 (vote pending finalization). No state-level peptide restrictions beyond federal law in South Dakota.
category: no approval · last verified May 13, 2026
§ 01
Quick answer
No FDA approval; WADA explicitly names AOD-9604 as a prohibited example under S2.2; PCAC discussed December 4, 2024 (vote pending finalization). No state-level peptide restrictions beyond federal law in South Dakota.
§ 02
Full status breakdown
Federal status
FDA approval
no approval
DEA scheduling
not scheduled
503A compounding
FDA Warning Letters
- Jan 26, 2022 — Innoveix Pharmaceuticals Inc. (cited: aod-9604, sermorelin, ipamorelin) · letter ↗
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Standard FDA posture — RUO does not protect sellers when human-use intent is evident.
Personal possession: Not federally scheduled; possession not federally criminalized.
South Dakota — state-specific
Sport-body status
WADA 2026
on prohibited list · class S2.2 · both
Explicitly named: WADA's growth-hormone narrative specifically lists AOD-9604 and hGH 176-191 as prohibited examples.
USADA
banned
NCAA
banned
What we couldn’t verify
§ 03
Also known as
AOD-9604 is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):
hGH fragment 176-191Advanced Obesity Drug 9604Tyr-hGH(177-191)AOD9604 acetate
§ 04
Disclaimer
§ 05
Related
- Back to peptide legality lookup — pick a different compound or state
- AOD-9604 research guide — mechanism, dosing math, vendor audits, COA data
- Peptide pricing index — what each compound costs per mg across audited vendors
- Janoshik COA verifier — a separate question from legality: does the COA the vendor cites actually exist?
the roundup · monthly
Receipts in your inbox. Once a month.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.
14,200 subscribers· 0 sponsored items· 11 issues since launch